US · Healthcare

Gossamer Bio Inc (GOSS)

Biotechnology

Gossamer Bio Inc (GOSS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $49.31M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for GOSS

Market cap
$49.31M
P/E ratio
25.00
Gross profit (TTM)
$55.54M
Net margin
0.0%

Gossamer Bio Inc (GOSS) — FAQ

What is Gossamer Bio Inc's market cap?

Gossamer Bio Inc (GOSS) has a reported market cap of $49.31M (data as of 2026-05-24).

What is GOSS's P/E ratio?

The price-to-earnings (P/E) ratio for Gossamer Bio Inc (GOSS) is 25.00 (data as of 2026-05-24).

Does Gossamer Bio Inc pay a dividend?

Dividend yield is not available in the current snapshot for Gossamer Bio Inc (GOSS). Check the MyAverix Finance app for the latest dividend data.

What sector is Gossamer Bio Inc in?

Gossamer Bio Inc (GOSS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GOSS listed on?

GOSS is listed on US.

What is Gossamer Bio Inc's net margin?

Gossamer Bio Inc (GOSS) reports a net margin of 0.0% (data as of 2026-05-24).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play